Australian female infertility diagnosis and treatment market is expected to witness a significant growth with the CAGR of 3.8% during the forecast period. The inability to conceive may occur in both men and women, however, infertility among women is more common. There are several factors that cause infertility among women such as exceeding 35 years of age, unhealthy lifestyle and genetic disorders. The market is driven by the growth in the number of infertility cases along with the extensive development of advanced technologies such as Assisted Reproductive Technology (ART) and Intrauterine Insemination (IUI).
In addition, the female infertility diagnosis and treatment diagnosis and treatment market are also growing due to the increasing trend of surrogacy, inclination towards in-vitro fertilization (IVF) treatment and rising population of women marrying in the late 30s. Change in the lifestyle among women is also considered as the major factor that tends to affect female fertility. The consumption of inadequate diet and body weight plays a major role in growing infertility among women. Overweight or underweight is one of the factors that affect the hormone production and affect the ovulation process.
To Request a Sample of our Report on Australian Female Infertility Diagnosis and Treatment Market: https://www.omrglobal.com/request-sample/australia-female-infertility-market
Australian female infertility diagnosis and treatment market is segmented on the basis of diagnosis, treatment type, and end-user. Based on the diagnosis, the market is segmented into ovulation testing, hysterosalpingography (HSG), hysteroscopy, imaging testing, ovarian reserve testing, hormonal level testing, genetic testing, and others (laparoscopy). Based on the treatment type, the market is segmented into drugs, surgery, intrauterine insemination (IUI), and assisted reproductive technology (ART). Based on the end-user, the market is segmented into hospitals and clinics, homecare, and pathology and diagnostic center.
(Get 15% Discount on Buying this Report)
A full Report of Australian Female Infertility Diagnosis and Treatment Market is Available @ https://www.omrglobal.com/industry-reports/australia-female-infertility-market
Australian Female Infertility Diagnosis and Treatment Market Segmentation
By Diagnosis
- Ovulation Testing
- Hysterosalpingography (HSG)
- Hysteroscopy
- Imaging Testing
- Ovarian Reserve Testing
- Hormonal Level Testing
- Genetic Testing
- Others (Laparoscopy)
By Treatment
- Drugs
- Surgery
- Intrauterine Insemination (IUI)
- Assisted Reproductive Technology (ART)
By End-User
- Hospitals and Clinics
- Homecare
- Pathology and Diagnostic Centers
Company Profiles
- Genea Ltd.
- Bayer AG
- Pfizer
- 6.4. Merck KGaA
- Church & Dwight Co., Inc.
- Vitrolife
- Cook Medical, Inc.
- Eli Lilly & Co.
- GlaxoSmithKline Plc.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
